First Quadrant’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-900
Closed -$191K 814
2014
Q4
$191K Sell
900
-100
-10% -$19.9K ﹤0.01% 533
2014
Q3
$178K Buy
1,000
+300
+43% +$49.8K ﹤0.01% 565
2014
Q2
$118K Sell
700
-93,700
-99% -$14.6M ﹤0.01% 625
2014
Q1
$11.7M Buy
94,400
+50,600
+116% +$6.16M 0.27% 117
2013
Q4
$4.87M Buy
43,800
+43,300
+8,660% +$4.14M 0.11% 198
2013
Q3
$45K Sell
500
-109,100
-100% -$9.79M ﹤0.01% 692
2013
Q2
$9.23M Buy
+109,600
New +$11.4M 0.25% 120

Other funds holding AGN

First Quadrant's AGN Position: Q1 2015 in Review

First Quadrant sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 900 shares — an estimated $191K sold.

First Quadrant first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $11.7M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • First Quadrant reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • First Quadrant sold 900 Allergan Inc shares in Q1 2015, an estimated $191K.
  • First Quadrant first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • First Quadrant's Allergan Inc position peaked at $11.7M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on First Quadrant's 13F filing for Q1 2015, filed 28 Apr 2015.